Skip to main content
PLOS One logoLink to PLOS One
. 2022 Nov 23;17(11):e0278101. doi: 10.1371/journal.pone.0278101

Trends in health expectancy at age 60 in Bangladesh from 1996 to 2016

Md Ismail Tareque 1,*
Editor: Allen Prabhaker Ugargol2
PMCID: PMC9683622  PMID: 36417472

Abstract

Background

Life expectancy (LE) is increasing all over the world, and relying on LE alone is no longer sufficient to identify whether a country is having a healthier population. Examining the increase in LE in relation to health ― health expectancy estimation ― is advised to ascertain the increase (or decrease) in LE without disability over time. This study examines the trends in health expectancy at age 60 in Bangladesh from 1996 to 2016.

Methods

Mortality information from United Nations and World Health Organization and morbidity information from Bangladesh Bureau of Statistics were combined using the Sullivan method.

Results

With an overall declining trend over the study period and a big drop in disability rates during 2012–2013, the disability rates were observed 1.6–1.7% in 2016. The declining trend in disability may have two-fold implications: (1) among the 98.3% older adults (≥60 years) with no severe/extreme disability, those were in jobs could have continued their work if there was no mandatory retirement at age 59, and (2) the 1.7% (translates into 0.2 million in 2020) older adults with severe/extreme disability require care assistance with their daily activities. The observed gain in disability-free life expectancy, the decrease in life expectancy with disability and its proportion allude to the compression of morbidity and healthier older adults over time.

Conclusion

In 2020, Bangladesh had 13.2 million (i.e., 8% of the total population) older adults, which is increasing day by day. The policy makers and government are suggested to prioritize the issues of older adults, particularly disability, care needs, retirement age, and health in the light of the current study’s findings. Utilizing health expectancy research is suggested to understand the combined effect of disability and mortality for considering policy changes.

Introduction

Life expectancy (LE), gauged on the basis of mortality indicators alone, has been increasing all over the world gradually for last two centuries, predominantly due to decline in early and mid-life mortality. Improvements in sanitation, housing, and education, continued with the development of vaccines and antibiotics have resulted the decline in early and mid-life mortality, which was largely due to infections [1]. In some developed countries, the current continuing increase in LE is almost entirely attributable to the decline in late-life mortality, as there was little room for further reduction in early and mid-life mortality in late twentieth century [1]. Bangladesh is experiencing epidemiological and demographic transitions, where the LE at birth has also increased from 46.6 years in 1971 to 72.9 years in 2020, mainly due to decline in early life mortality [2]. However, this increase in LE may not imply a healthier population [3, 4]. Relying on mortality indicators alone is no longer sufficient to identify whether a country is having a healthier population over time; examining the increase in LE in relation to health ― health expectancy estimation ― is advised to ascertain the increase (or decrease) in LE without disability over time to signify a healthier (or unhealthier) population in a country [5].

Health expectancy is defined as “the analysis of both healthy and unhealthy years of life where health can be defined along various dimensions” [6]. As a holistic measure of population health, it combines length and quality of life into a single metric, and thus captures both quantity and quality of LE [79]. When computing health expectancy employing self-rated health (SRH), the terms healthy life expectancy (HLE) and unhealthy life expectancy (UHLE) conventionally refer to the LE spent in good and poor SRH, respectively [6, 10]. When computing health expectancy employing disability, the terms disability-free life expectancy (DFLE) and life expectancy with disability (DLE) conventionally refer to the LE spent without disability and with disability, respectively [6, 11, 12].

Health expectancies are increasingly employed to evaluate changes in population health status and functional dependency, particularly in respect of older adults [8, 13]. These have become very important for projecting future levels of care needs and assistance for the older adults in the developed regions of the world [14]. For example, health expectancies were utilized to identify whether there was compression or expansion of morbidity between 1986 and 2004 in Japan [5], and between 1970 and 2010 in the USA [15], whether the UK workers are expecting healthy working life till State Pension age [16], whether the UK government’s Ageing Society Grand Challenge (to increase the HLE by five years by 2035) will be attained [17], whether healthy life years are reduced for obese (versus normal weight) older adults [18], for hearing and/or vision impaired (versus non-impaired) older adults [19], and for lonely (versus non-lonely) older adults in Singapore [10]. However, there is a paucity of health expectancy research in developing countries.

In Bangladesh, some research on health expectancy exists, which reported DFLE, DLE, HLE and UHLE for people of all ages and older adults aged ≥60 years as well as HLE and UHLE for people aged ≥15 years at some points in time [11, 12, 20, 21]. In addition, a study reported partial work-loss free LE and its changes between 2004 and 2007 for men aged 30–54 years [22], and a study reported LE with and without hypertension for people aged ≥35 years [23]. In Bangladesh, at age 60, despite having longer LE, women have a greater prevalence of disability and shorter DFLE than men [12]. Inequalities in LE, DFLE and DLE between rural and urban areas are reported; urban males and females, respectively, have a longer DFLE and shorter DLE both in number and proportion when compared to rural males and females [11]. HLE declines with the increase in age in Rajshahi district of Bangladesh [20]. Men expected fewer LE spent in good SRH but a much larger proportion of LE in good SRH than did women in Bangladesh in 1996 and 2002 [21]. The study on partial work-loss free LE found improvements in the average number of work-loss days as well as in work-loss free LE among men from 2004 to 2007; workers at age 30 in 2007 expected 212 days more work-loss free LE than workers of the same age in 2004 [22]. The study on LE with and without hypertension reported that women (versus men) could expect shorter LE without hypertension at all ages, in terms of both number and proportion of years [23].

The above statistics point to the availability of the levels of health expectancy at different ages at different points in time; but there is no study that has examined the trends in health expectancy at age 60 in Bangladesh. This study, therefore, examines the trends in health expectancy, particularly the trends in both HLE/ DFLE and UHLE/ DLE at age 60 in Bangladesh from 1996 to 2016. This trend analysis will help identify the compression or expansion of morbidity (i.e., poor health/ disability) between 1996 and 2016, thus, help appraise whether Bangladesh is having healthier older adults, consequently may help redefine retirement age. This analysis will be useful in monitoring older adults’ health over time as well.

Methods

To compute health expectancy, two key pieces of information (specifically, mortality and morbidity) are needed. Mortality information, particularly age- and sex-specific mortality rates and LE can be obtained from a standard period life table. Morbidity information, particularly age- and sex-specific prevalence or proportions of SRH/ disability can be obtained from a cross-sectional survey for the same period as the standard life table. Available mortality and morbidity data for Bangladesh along with their formats and sources are discussed in detail in (S1 Text). Only analytical data are discussed below.

Analytical data

Mortality information

Five-yearly abridged life tables for 1995–2000 and 2000–2005 from World Population Prospects 2019, and yearly abridged life tables from 2009 to 2016 from World Health Organization’s Global Health Observatory data repository were utilized (S1 Text).

Morbidity information

SRH status from the World Values Survey (WVS) for 1996 and 2002, and yearly disability prevalence for 2009–2016 from the Sample Vital Registration System (SVRS) 2010, 2012–2013, Bangladesh Sample Vital Statistics (BSVS) 2014–2018 were utilized (S1 Text).

Analysis

At first, the prevalence of poor SRH for 1996 and 2002 and prevalence of disability from 2009 to 2016 by age-group and gender were calculated using Stata/MP version 13.0 (StataCorp LP, College Station, Texas, USA). Then annual percent change in disability from 2009 to 2016 (and annual percent change in poor SRH for 1996 and 2002) are measured using the following formula:

Annualpercentchangeindisability=Dt2Dt1Dt1×(t2t1)×100

Where Dt1 and Dt2 are disability rates at time t1 and t2, respectively.

A positive value indicates increment in disability, and a negative value indicates decrement in disability.

Necessary columns of the life tables and disability prevalence from 2009 to 2016 (and prevalence of poor SRH for 1996 and 2002) were combined using the Sullivan method [24] to compute health expectancy in the current study. There are the two main methods of health expectancy computation─ the Sullivan method is a prevalence-based method, and others (e.g., multistate life table method) are incidence-based methods [6, 25]. Despite having some limitations in detecting sudden change in health transition rates, the Sullivan method is found acceptable for monitoring long term trends in health expectancies [26]. The concepts, methods and materials of health expectancy can be found elsewhere [6, 25, 27]. In the current study, health expectancy at age x was computed, separately for men and women, using the following formulas:

DFLEx(orHLEx)=1lxa=xwLa(1πa)
DLEx(orUHLEx)=1lxa=xwLaπa

Where, lx refers to the number of survivors at age x; La refers to the person-years lived for the age interval a, πa refers to disability prevalence from 2009 to 2016 (and prevalence of poor SRH for 1996 and 2002) in the age interval a, and w is the last age group of the life table. Details of the estimation procedure of the Sullivan method for calculating DFLEx (or HLEx) and DLEx (or UHLEx) are available elsewhere [28]. All health expectancy estimations for each year, separately for men and women, were performed with MS Excel.

Ethical considerations

This study does not need ethical approval, as it uses de-identified data from secondary sources.

Results

Disability prevalence

The prevalence of poor SRH for 1996 and 2002 and prevalence of disability from 2009 to 2016 and their annual percent change at age 60 from 1996 to 2016 in Bangladesh are provided in (S1 Table). Poor SRH status is utilized as a substitute for disability measure in 1996 and 2002, as information on disability is unavailable in 1996 and 2002. Around 264 men (per 1000) and 286 women (per 1000) were with poor SRH status in 1996. Fewer older men had poor SRH in 2002 than in 1996, and no woman had poor SRH in 2002. The disability rates and their annual percent change by gender from 2009 to 2016 are illustrated in Figs 1 and 2 to comprehend their trends.

Fig 1. Disability prevalence (per 1000) by gender at age 60 from 2009 to 2016.

Fig 1

Fig 2. Annual percent change in disability by gender at age 60 from 2010 to 2016.

Fig 2

As can be seen from Fig 1, at age 60, men and women were found to have almost similar rate of disability across years from 2009 to 2016 (Fig 1). Although disability has an overall declining trend from 2009 to 2016, there was a small increment in disability from 2009–2010, 2011–2012, and 2015–2016, a small decrement in disability from 2010–2011, and a large decrement from 2012–2013. Apparently, the disability rate remained almost stagnant (46–55 per 1000 older adults) from 2009 to 2012, then it decreased sharply to 14–17 (per 1000 older adults) in 2013. From 2013 to 2016, the disability rate remained almost stagnant (14–17 per 1000 older adults) again.

At age 60, for men and women respectively, there were 12.4% and 3.2% increment in disability in 2010, 16.5% and 12.5% decrement in disability in 2011, again 2.8% and 0.7% increment in 2012 (Fig 2). The largest decrements (69.8% for men and 62.5% for women) were observed in 2013. Although there were increment in disability among men and decrement in disability among women in 2014–2015, decrement among men and increment among women were found in 2016.

Health expectancy

Health expectancy, particularly DFLE and DLE, for men and women separately at age 60 from 1996 to 2016 is provided in Fig 3. For 1996 and 2002, DFLE represents HLE (i.e., LE with good SRH), and DLE represents UHLE (i.e., LE with poor SRH). In 1996, at age 60 an older man could expect to live 17.25 years, of which 12.70 years with good SRH and 4.55 years (26.38% of LE) with poor SRH, and an older woman could expect to live 17.85 years, of which 12.75 years with good SRH and 5.10 years (28.57% of LE) with poor SRH. In 2002, for both men and women, there were an increase in LE, an increase in LE with good SRH, a decrease in LE with poor SRH, and a decrease in proportion of LE with poor SRH (Fig 3).

Fig 3. Health expectancy by gender at age 60 from 1996 to 2016.

Fig 3

Notes: For 1996 and 2002, DFLE represents life expectancy with good self-reported health; DLE represents life expectancy with poor self-reported health; DFLE: Disability-free life expectancy; DLE: Life expectancy with disability; LE: Life expectancy.

For both men and women, an increase in LE, an increase in DFLE, a decrease in DLE, and a decrease in proportion of LE with disability, with a few exceptions, across years from 2009 to 2016 were observed. Among men at age 60, there were 0.55 year increase in LE, 0.83 year increase in DFLE, and 0.28 year decrease in DLE in 7 years from 2009 to 2016 (See Panel-A, Fig 3). In 2009, an older man at age 60 could expect to live 18.01 years, of which 17.13 years without disability and 0.88 year (4.89% of LE) with disability. In 2016, an older man at age 60 could expect to live 18.56 years, of which 17.96 years without disability and 0.60 year (3.23% of LE) with disability.

Among women at age 60, there were 2 year increase in LE, 2.88 year increase in DFLE, and 0.88 year decrease in DLE in 7 years from 2009 to 2016 (See Panel-B, Fig 3). In 2009, an older woman at age 60 could expect to live 18.88 years, of which 17.92 years without disability and 0.96 year (5.08% of LE) with disability. In 2016, an older woman at age 60 could expect to live 20.88 years, of which 20.80 years without disability and 0.08 year (0.38% of LE) with disability.

Compared to men, women had longer LE and longer DFLE across years from 2009 to 2016, longer DLE from 2009 to 2012 but shorter DLE from 2013 to 2016 (Fig 4). Compared to men, women had similar proportion of LE with disability from 2009 to 2012, but significantly shorter proportion of LE with disability from 2013 to 2016.

Fig 4. Trends in health expectancy at age 60 from 2009 to 2016.

Fig 4

Notes: DFLE: Disability-free life expectancy; DLE: Life expectancy with disability; LE: Life expectancy.

Discussion

To my knowledge, this is the first study on the trends in health expectancy in Bangladesh. Using data from secondary sources, this study reveals some important insights, which have significant implications for disability, care needs, health expectancy, retirement and healthy aging in Bangladesh. Along with assessing poor SRH prevalence, HLE and UHLE in 1996 and 2002, the current study predominantly focuses on the trends in disability, DFLE, DLE, and proportion of LE with disability at age 60 from 2009 to 2016. With an overall declining trend over the study period and a big drop in disability rates during 2012–2013, the disability rates were observed almost stagnant at 46–55 (per 1000 older adults) during 2009–2012 and at 14–17 (per 1000 older adults) during 2013–2016. In 7 years from 2009 to 2016, at age 60, for men and women, respectively, there were 0.55 and 2.00 years increase in LE, 0.83 and 2.88 years increase in DFLE, and 0.28 and 0.88 year decrease in DLE. The decrease in the proportion of LE with disability was 1.65 percentage point for men and 4.70 percentage point for women from 2009 to 2016. Compared to men, women had longer LE and longer DFLE across years from 2009 to 2016, longer DLE (translating into similar proportion of LE with disability) from 2009 to 2012, but shorter DLE (translating into significantly shorter proportion of LE with disability) from 2013 to 2016.

Bangladesh, with a mandatory retirement age of 59 in most government and private job sectors [29, 30], defines old-age as ≥60 years in the National Policy on Older Persons 2013. The disability rate coupled with the proportion of LE with disability at age 60 from the current study thus bear significant implications for redefining retirement age in Bangladesh. The disability rates observed in the current study (i.e., 4.6–5.5% during 2009–2012, reported in SVRS 2010 and 2012) are lower than that of HIES 2010, mainly due to using different approaches for measuring disability [12, 31, 32]. For instance, 42% of older adults had some form of functional disability, including 5% of older adults with severe/extreme functional disability, and 7% of older adults had a self-care disability, including 3% of older adults with a severe/extreme form of self-care disability in 2010 [32]. In 2010, ‘some disability’ were prevalent among 28.4% men and 34.8% women in the age group of 60–64 years, 32.2% men and 40.4% women in the age group of 65–69 years, 43.9% men and 52.1% women in the age group of 70–74 years, and so on [12]. Although, the same indicators ― Washington Group’s short set of six questions ― were adopted in all of SVRS 2010, 2012–2013, BSVS 2014–2016, and HIES 2010, the definition of disability ― how the disability was measured from the six indicators ― is not explicitly stated in SVRS 2010, 2012–2013, and BSVS 2014–2016. Different cut-offs from the same Washington Group’s short set of six questions produce different estimates [11]. Apparently, the observed disability rates in the current study are close to those with severely/extremely disabled in HIES 2010 [31], signifying that the severe/extreme form of disability in any of Washington Group’s short set of six questions was considered as disability in SVRS 2010, 2012–2013, and BSVS 2014–2016. This conservative cut-off (i.e., severe/extreme disability in any of the six tasks) has not been utilized to define disability in the extant literature in Bangladesh [11, 12] and in other settings [3335]. Further, such conservative definition of disability minimizes specificity, such that those designated as ‘without disability’ may have ‘some difficulty’ with two or more of the Washington Group’s recommended six tasks, and may not be able to perform a comprehensive range of activities that are required for independent living, particularly at ≥60 years. Thus, instead of conservative cut-off, adopting prudent and practicable cut-off for measuring disability, particularly for older adults, is warranted. Practicable cut-off may contemplate an individual as disabled if s/he is having ‘severe difficulty’ with any of the six indicators, or being unable (‘extreme difficulty’) to perform any of the six indicators at all, or having ‘some difficulty’ with at least two of the six indicators [11, 3335]. In addition, an explicit definition with cut-offs to measure disability from the Washington Group’s short set of six questions in upcoming government reports (e.g., BSVS) is vital.

To my knowledge, no intervention was made during 2012–2013 or earlier that could reduce disability rate among older adults from 2012 to 2013. However, the declining trend in disability indicates only 1.6–1.7% of older adults were disabled at age ≥60 in 2016, leaving more than 98.3% of older adults with no severe/extreme disability for functional and self-care activities. In 2020, 1.7% of Bangladesh older adults translates into 0.2 million people of age ≥60 years [36]. The declining trend in disability, with an indication of compression of morbidity, may have two-fold implications: (1) among the 98.3% older adults with no severe/extreme disability, those were in jobs could have continued their work if there was no mandatory retirement at age 59, and (2) the 1.7% older adults with severe/extreme disability require care assistance with their daily activities, and thus monitoring is suggested whether those older adults receive necessary care and support. Policy makers and government should place emphasis on this two-fold implications to make the older adults healthy and able to do their daily activities and work successfully.

In 7 years from 2009 to 2016, for men and women, respectively, there were 0.55 and 2.00 years increase in LE. Declining neonatal, infant, child and maternal mortality are the main drivers for these increases in LE. The gain in LE is lower for men than women. The causes of death that most contribute to a lower LE for men than women are ischaemic heart disease, road injuries, lung cancer, chronic obstructive pulmonary disease, stroke, cirrhosis of the liver, tuberculosis, prostate cancer [37]. Declining maternal mortality may also contribute to extra gain in LE for women than men. In 7 years from 2009 to 2016, the gain in DFLE is greater than the gain in LE, and there was a decrease in DLE. The gain in DFLE, the decrease in DLE and the decrease in the proportion of LE with disability allude strongly to the compression of morbidity during 2009–2016. These also indicate that Bangladesh is having healthier older adults over time. The primary reason for the gain in DFLE is the decline in disability rates over time. In addition, medical advances may be reducing the likelihood that diseases progress to disabling conditions [38]. Maintaining health and reducing disability at younger ages are suggested to have meaningful compression of morbidity at older ages as well as healthier older adults [15]. Behavioral risk factors (smoking, physical inactivity, obesity, alcohol consumption, and unhealthy lifestyle) [18, 3942], hearing and vision impairments [19], sleep disturbances [43], and loneliness [10] are found to be contributors to shorter LE and shorter HLE/DFLE in different settings. These factors may be taken into consideration to further improve the DFLE among older adults in Bangladesh. The current study mainly demonstrates the value of utilizing health expectancy research to understand the combined effect of trends in disability and mortality for considering policy changes (e.g., definition of older adults, retirement age, prioritizing health expectancy research and healthy aging).

Women (versus men) had longer LE, longer DFLE across years from 2009 to 2016, longer DLE (i.e., similar proportion of LE with disability) from 2009 to 2012, but shorter DLE (i.e., significantly shorter proportion of LE with disability) from 2013 to 2016. Due to having similar rate of disability among men and women in the current study, longer LE and longer DFLE among women than men may be attributable to survival and biological sex differences [37]. Longer LE and longer DFLE among women than men in the current study are contrary to the findings that women have shorter DFLE than men, in numbers and proportion [12]. Using different cut-offs for disability measurement in the earlier study [12] and the current ones are the possible reasons. More investigation on the gender differences in the trends in health expectancy is indispensable.

I acknowledge a few limitations of this study. The self-reported disability was utilized in the current study that could be a possible source of bias, though the self-reported functional disability was found to be consistent with medical diagnoses [44]. The SRH was also utilized as a measure of morbidity, which may have introduced gender bias in the findings [45]. The single-item SRH was however reported to be able to capture almost the same as objective health status in predicting a short-term mortality among older adults [46]. Due to unavailability of same morbidity measure across the study period, two different subjective morbidity measures ─ SRH and disability ─ were utilized in the current study. They both were found to be consistent with their objective measures, and were reported to predict mortality among older adults in different settings [44, 46, 47]. Institutionalized populations were not interviewed in SVRS 2010, 2012–2013, and BSVS 2014–2016, but life tables were computed based on the mortality information of all institutionalized and non-institutionalized (i.e., community people). The DFLE might either be over-estimated if institutionalized populations had higher disability rates than community people, or under-estimated if the institutionalized populations had lower disability than community people. The same disability rate was assumed for both the institutionalized and non-institutionalized populations in the current study. Some older adults might have been unable to respond to the interviewers, and some proxy respondents instead might have been interviewed in SVRS 2010, 2012–2013, and BSVS 2014–2016. The SVRS and BSVS stated nothing about proxy respondents. Disability rates for the year 2017 and 2018 are available in BSVS 2017 and 2018, but are not used for this study due to unavailability of yearly life table for the year 2017 and 2018 in the World Health Organization’s Global Health Observatory data repository. LE at birth in 2017 (Male: 70.6 years; Female: 73.5 years) and 2018 (Male: 70.8 years; Female: 73.8 years) in Reports on Bangladesh Sample Vital Statistics 2017 and 2018 are lower than that in 2016 (Male: 71.1 years; Female: 74.4 years) in World Health Organization’s Global Health Observatory data repository. Inclusion of life tables for 2017 and 2018 from Reports on Bangladesh Sample Vital Statistics may not represent the proper trends in LE; thus, trends in health expectancy was not extended to 2017 or 2018.

Conclusion

Bangladesh is not yet considered an ‘aging society,’ but in 2020, it had 13.2 million (i.e., 8% of the total population) people aged ≥60 years, which is more than the total population of some countries (e.g., in 2020, Singapore’s total population is 5.9 million, and China, Hong Kong SAR’s total population is 7.5 million [36]). The number of the older adults is increasing day by day. The policy makers and government are suggested to prioritize the problems and issues of the older adults, particularly disability, care needs, retirement age, and health in the light of the current study’s findings. Utilizing health expectancy research is suggested to understand the combined effect of disability and mortality for considering policy changes for older adults in Bangladesh.

Supporting information

S1 Text. Available data.

(DOCX)

S1 Table. Poor SRH/ disability prevalence (per 1000) and annual percent change in poor SRH/ disability by gender at age 60 from 1996 to 2016.

(DOCX)

Data Availability

All data are held in public repositories. The sources are mentioned in the Supporting information (S1 Text). Nationally representative data on SRH status by age and gender access can be obtained at www.worldvaluessurvey.org.

Funding Statement

This study received support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). There was no additional external funding received for this study. The Faculty of Science, University of Rajshahi had no role in the study design, or interpretation of the results, or preparation, or approval of the manuscript.

References

  • 1.Zhaurova K. Genetic causes of adult-onset disorders. Nat Educ. 2008;1: 49. [Google Scholar]
  • 2.Bank World. Life expectancy at birth, total (years)—Bangladesh. 2022. [cited 4 Oct 2022]. Available: https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=BD [Google Scholar]
  • 3.Crimmins EM, Hayward MD, Saito Y. Changing mortality and morbidity rates and the health status and life expectancy of the older population. Demography. 1994;31: 159–175. doi: 10.2307/2061913 [DOI] [PubMed] [Google Scholar]
  • 4.Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, et al. Inequalities in healthy life years in the 25 countries of the European Union in 2005: A cross-national meta-regression analysis. Lancet. 2008;372: 2124–2131. doi: 10.1016/S0140-6736(08)61594-9 [DOI] [PubMed] [Google Scholar]
  • 5.Yong V, Saito Y. Trends in healthy life expectancy in Japan: 1986–2004. Demographic Res. 2009;20: 467–494. [Google Scholar]
  • 6.Saito Y, Robine J-M, Crimmins EM. The methods and materials of health expectancy. Stat J IAOS. 2014;30: 209–223. doi: 10.3233/SJI-140840 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.New Zealand Ministry of Social Development. Health expectancy: The Social Report 2016. –Te pūrongo oranga tangata. 2016 [cited 1 Mar 2019]. Available: http://socialreport.msd.govt.nz/health/health-expectancy.html [Google Scholar]
  • 8.Robine J-M, Romieu I, Cambois E. Health expectancy indicators. Bull World Health Organ. 1999;77: 181–185. [PMC free article] [PubMed] [Google Scholar]
  • 9.Sanders BS. Measuring community health levels. Am J Public Health Nations Health. 1964;54: 1063–1070. doi: 10.2105/ajph.54.7.1063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Malhotra R, Tareque MI, Saito Y, Ma S, Chiu C-T, Chan A. Loneliness and health expectancy among older adults: A longitudinal population-based study. J Am Geriatr Soc. 2021;69: 3092–3102. doi: 10.1111/jgs.17343 [DOI] [PubMed] [Google Scholar]
  • 11.Islam MdS Tareque MdI, Mondal MdNI Fazle Rabbi AM, Khan HTA, Begum S. Urban-rural differences in disability-free life expectancy in Bangladesh using the 2010 HIES data. PLoS One. 2017;12. doi: 10.1371/journal.pone.0179987 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tareque MI, Begum S, Saito Y. Gender differences in disability-free life expectancy at old ages in Bangladesh. J Aging Health. 2013;25: 1299–1312. doi: 10.1177/0898264313501388 [DOI] [PubMed] [Google Scholar]
  • 13.Kingston A, Wohland P, Wittenberg R, Robinson L, Brayne C, Matthews FE, et al. Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS). Lancet. 2017;390: 1676–1684. doi: 10.1016/S0140-6736(17)31575-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kingston A, Comas-Herrera A, Jagger C. Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim) modelling study. Lancet Public Health. 2018;3: e447–e455. doi: 10.1016/S2468-2667(18)30118-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Crimmins EM, Zhang Y, Saito Y. Trends over 4 decades in disability-free life expectancy in the United States. Am J Public Health. 2016;106: 1287–1293. doi: 10.2105/AJPH.2016.303120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Parker M, Bucknall M, Jagger C, Wilkie R. Population-based estimates of healthy working life expectancy in England at age 50 years: analysis of data from the English Longitudinal Study of Ageing. Lancet Public Health. 2020;5: e395–e403. doi: 10.1016/S2468-2667(20)30114-6 [DOI] [PubMed] [Google Scholar]
  • 17.Welsh CE, Matthews FE, Jagger C. Trends in life expectancy and healthy life years at birth and age 65 in the UK, 2008–2016, and other countries of the EU28: An observational cross-sectional study. Lancet Reg Health Eur. 2021;2: 100023. doi: 10.1016/j.lanepe.2020.100023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tareque MI, Saito Y, Chan A, Visaria A, Ma S, Malhotra R. Years of life with and without limitation in physical function and in activities of daily living by body mass index among older adults. Int J Obes. 2019;43: 2244–2253. doi: 10.1038/s41366-019-0370-8 [DOI] [PubMed] [Google Scholar]
  • 19.Tareque MI, Chan A, Saito Y, Ma S, Malhotra R. The impact of self-reported vision and hearing impairment on health expectancy. J Am Geriatr Soc. 2019;67: 2528–2536. doi: 10.1111/jgs.16086 [DOI] [PubMed] [Google Scholar]
  • 20.Tareque MI, Islam TM, Kawahara K, Sugawa M, Saito Y. Healthy life expectancy and the correlates of self-rated health in an ageing population in Rajshahi district of Bangladesh. Ageing Soc. 2015;35: 1075–1094. doi: 10.1017/S0144686X14000130 [DOI] [Google Scholar]
  • 21.Tareque MI, Saito Y, Kawahara K. Healthy life expectancy and the correlates of self-rated health in Bangladesh in 1996 and 2002. BMC Public Health. 2015;15. doi: 10.1186/s12889-015-1640-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tareque MI, Saito Y, Kawahara K. Application of health expectancy research on working male population in Bangladesh. Asian Popul Stud. 2015;11: 32–43. doi: 10.1080/17441730.2015.1007558 [DOI] [Google Scholar]
  • 23.Tareque MI, Saito Y. Gender differences in hypertension-free life expectancy in Bangladesh. Int J Popul Stud. 2017;3: 110–120. doi: 10.18063/ijps.2017.01.004 [DOI] [Google Scholar]
  • 24.Sullivan DF. A single index of mortality and morbidity. HSMHA health reports. 1971;86: 347. [PMC free article] [PubMed] [Google Scholar]
  • 25.Mathers CD. Health expectancies: an overview and critical appraisal. Summary measures of population health: concepts, ethics, measurement and applications. 2002; 177–204. [Google Scholar]
  • 26.Mathers CD, Robine JM. How good is Sullivan’s method for monitoring changes in population health expectancies? J Epidemiol Community Health. 1997;51: 80–86. doi: 10.1136/jech.51.1.80 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Robine J-M, Jagger C, Mathers CD, Crimmins EM, Suzman RM. Determining health expectancies. John Wiley & Sons; 2002. [Google Scholar]
  • 28.Jagger C, Van Oyen H, Robine J-M. Health expectancy calculation by the Sullivan method: a practical guide. Nihon University Population Research Institute (NUPRI) Research Paper Series. 2014. [Google Scholar]
  • 29.Dewan AA. Economics and well-being of retiring in Bangladesh. The Financial Express. 2019. Available: https://thefinancialexpress.com.bd/views/economics-and-well-being-of-retiring-in-bangladesh-1573829939. Accessed 14 Jul 2021. [Google Scholar]
  • 30.Trading Economics. Bangladesh retirement age. 2021. [cited 14 Jul 2021]. Available: https://tradingeconomics.com/bangladesh/retirement-age-men [Google Scholar]
  • 31.Bangladesh Bureau of Statistics. Disability in Bangladesh: Prevalence and Pattern. Bangladesh Bureau of Statistics (BBS), Statistics and Informatics Division (SID), Ministry of Planning; 2015. Available: http://203.112.218.65:8008/WebTestApplication/userfiles/Image/PopMonographs/disabilityFinal.pdf [Google Scholar]
  • 32.Tareque MI, Tiedt AD, Islam TM, Begum S, Saito Y. Gender differences in functional disability and self-care among seniors in Bangladesh. BMC Geriatr. 2017;17: 177. doi: 10.1186/s12877-017-0577-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Mitra S, Posarac A, Vick B. Disability and poverty in developing countries: a multidimensional study. World Dev. 2013;41: 1–18. [Google Scholar]
  • 34.Mitra S, Sambamoorthi U. Disability prevalence among adults: estimates for 54 countries and progress toward a global estimate. Disabil Rehabil. 2014;36: 940–947. doi: 10.3109/09638288.2013.825333 [DOI] [PubMed] [Google Scholar]
  • 35.Wandera SO, Ntozi J, Kwagala B. Prevalence and correlates of disability among older Ugandans: evidence from the Uganda National Household Survey. Glob Health Action. 2014;7: 25686. doi: 10.3402/gha.v7.25686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2019. 2019. [cited 6 Apr 2020]. Available: https://population.un.org/wpp/ [Google Scholar]
  • 37.World Health Organization. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. World Health Organization; 2019. [Google Scholar]
  • 38.Crimmins EM, Saito Y, Ingegneri D. Trends in disability-free life expectancy in the United States, 1970–90. Popul Dev Rev. 1997;23: 555–572. doi: 10.2307/2137572 [DOI] [Google Scholar]
  • 39.Daskalopoulou C, Koukounari A, Wu Y-T, Terrera GM, Caballero FF, de la Fuente J, et al. Healthy ageing trajectories and lifestyle behaviour: the Mexican Health and Aging Study. Sci Rep. 2019;9: 11041. doi: 10.1038/s41598-019-47238-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Stenholm S, Head J, Kivimäki M, Kawachi I, Aalto V, Zins M, et al. Smoking, physical inactivity and obesity as predictors of healthy and disease-free life expectancy between ages 50 and 75: A multicohort study. Int J Epidemiol. 2016;45: 1260–1270. doi: 10.1093/ije/dyw126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Stenholm S, Head J, Aalto V, Kivimäki M, Kawachi I, Zins M, et al. Body mass index as a predictor of healthy and disease-free life expectancy between ages 50 and 75: A multicohort study. Int J Obes. 2017;41: 769–775. doi: 10.1038/ijo.2017.29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zaninotto P, Head J, Steptoe A. Behavioural risk factors and healthy life expectancy: evidence from two longitudinal studies of ageing in England and the US. Sci Rep. 2020;10: 6955. doi: 10.1038/s41598-020-63843-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Stenholm S, Head J, Kivimäki M, Magnusson Hanson LL, Pentti J, Rod NH, et al. Sleep duration and sleep disturbances as predictors of healthy and chronic disease–free life expectancy between ages 50 and 75: A pooled analysis of three cohorts. J Gerontol A Biol Sci Med Sci. 2019;74: 204–210. doi: 10.1093/gerona/gly016 [DOI] [PubMed] [Google Scholar]
  • 44.Zunzunegui M-V, Alvarado B-E, Béland F, Vissandjee B. Explaining health differences between men and women in later life: A cross-city comparison in Latin America and the Caribbean. Soc Sci Med. 2009;68: 235–242. doi: 10.1016/j.socscimed.2008.10.031 [DOI] [PubMed] [Google Scholar]
  • 45.Case A, Paxson C. Sex differences in morbidity and mortality. Demography. 2005;42: 189–214. doi: 10.1353/dem.2005.0011 [DOI] [PubMed] [Google Scholar]
  • 46.Wuorela M, Lavonius S, Salminen M, Vahlberg T, Viitanen M, Viikari L. Self-rated health and objective health status as predictors of all-cause mortality among older people: a prospective study with a 5-, 10-, and 27-year follow-up. BMC Geriatr. 2020;20: 120. doi: 10.1186/s12877-020-01516-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gobbens RJ, van der Ploeg T. The prediction of mortality by disability among Dutch community-dwelling older people. Clin Interv Aging. 2020;15: 1897–1906. doi: 10.2147/CIA.S271800 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Allen Prabhaker Ugargol

20 Sep 2022

PONE-D-22-03689Trends in health expectancy at age 60 in Bangladesh from 1996 to 2016PLOS ONE

Dear Dr. Tareque,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE does not copy edit accepted manuscripts (https://journals.plos.org/plosone/s/criteria-for-publication#loc-5). To that effect, please ensure that your submission is free of typos and grammatical errors.

3. Thank you for stating in your Funding Statement:

“This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The Faculty of Science, University of Rajshahi had no role in the study design, or interpretation of the results, or preparation, or approval of the manuscript.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study is a very novel attempt in the context of Bangladesh. The study has estimated and examined the trends in "Health expectancy", one of the new and intuitive measure of understanding health status of a population. As research in the context of Bangladesh has been largely concentrated around maternal and child health, this timely piece will provide a foresight for the country's policymaker to tackle ageing related health-issues in coming years.

The paper has articulated its findings very clearly along with cited all previously published major research works in this area. The paper well-written and show a decent presentation of the results. However, I would like to mention few points which can be included in the work if the author feels so.

1. A short discussion on Sullivan's method including its limitations (will be useful for readers new in the field).

2. The author may consider to include the supplementary figures 1 and 2 to the main document.

Reviewer #2: The authors attempt to provide essential insights on disability free life expectancy and correctly summarize its necessity vis-à-vis just LE. It is a timely assessment given the ageing population in Bangladesh.

Major concerns:

1. The authors provide information on various data sources available for disability and life tables- can be shifted to supplementary . They must mention and with details only the data sets used in main manuscript.

2. Since SRH and disability rates are both used, the authors should provide more information on the pros and cons of these- and justify a comparison across time with two different measures.

3. The introduction should focus more on literature about SRH and disability instead of various uses of disability free life expectancy

Minor suggestions:

1. Abstract- implications should be discussed in text and mention only major findings here

2. Introduction- line 94: can be just "or USA" instead of repeating entire sentence again

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Nov 23;17(11):e0278101. doi: 10.1371/journal.pone.0278101.r002

Author response to Decision Letter 0


9 Oct 2022

Journal Requirements:

Comment: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: I have formatted the manuscript in accordance with PLOS ONE’s style requirements.

Comment: 2. PLOS ONE does not copy edit accepted manuscripts (https://journals.plos.org/plosone/s/criteria-for-publication#loc-5). To that effect, please ensure that your submission is free of typos and grammatical errors.

Response: I have revised the manuscript to keep it free from typos and grammatical errors.

Comment: 3. Thank you for stating in your Funding Statement: “This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

Response: The study received only one small funding from the Faculty of Science, University of Rajshahi. I have removed “partial” from the statement, and included “There was no additional external funding received for this study.” to it. The following is the Amended Funding Statement, which is also provided in the cover letter.

“This study received support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). There was no additional external funding received for this study. The Faculty of Science, University of Rajshahi had no role in the study design, or interpretation of the results, or preparation, or approval of the manuscript.”

Comment: 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The Faculty of Science, University of Rajshahi had no role in the study design, or interpretation of the results, or preparation, or approval of the manuscript.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study received partial support from the Faculty of Science, University of Rajshahi (grant number: A-1155-5/52/RU/Science-34/19-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response: I have removed funding-related text from the manuscript. I have also amended the Funding statement, and provided the amended statement in the cover letter.

Comment: 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: I have included the caption for the Supporting Information file at the end of the revised manuscript, and updated the in-text citations to match accordingly.

Comment: 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: I have revised the list. Newly added references are highlighted in yellow.

Review Comments to the Author

Reviewer #1:

Comment: The study is a very novel attempt in the context of Bangladesh. The study has estimated and examined the trends in "Health expectancy", one of the new and intuitive measure of understanding health status of a population. As research in the context of Bangladesh has been largely concentrated around maternal and child health, this timely piece will provide a foresight for the country's policymaker to tackle ageing related health-issues in coming years.

The paper has articulated its findings very clearly along with cited all previously published major research works in this area. The paper well-written and show a decent presentation of the results. However, I would like to mention few points which can be included in the work if the author feels so.

Response: Thank you very much for your positive comments.

Comment: 1. A short discussion on Sullivan's method including its limitations (will be useful for readers new in the field).

Response: I appreciate your observation. To aid the new researchers in the field of health expectancy, the following is added to the Analysis section (lines# 158-164):

“…There are the two main methods of health expectancy computation─ the Sullivan method is a prevalence-based method, and others (e.g., multistate life table method) are incidence-based methods [6,25]. Despite having some limitations in detecting sudden change in health transition rates, the Sullivan method is found acceptable for monitoring long term trends in health expectancies [26]. The concepts, methods and materials of health expectancy can be found elsewhere [6,25,27]. In the current study,…”

6. Saito Y, Robine J-M, Crimmins EM. The methods and materials of health expectancy. Stat J IAOS. 2014;30: 209–223. doi:10.3233/SJI-140840

25. Mathers CD. Health expectancies: an overview and critical appraisal. Summary measures of population health: concepts, ethics, measurement and applications. 2002; 177–204.

26. Mathers CD, Robine JM. How good is Sullivan’s method for monitoring changes in population health expectancies? J Epidemiol Community Health. 1997;51: 80–86. doi:10.1136/jech.51.1.80

27. Robine J-M, Jagger C, Mathers CD, Crimmins EM, Suzman RM. Determining health expectancies. John Wiley & Sons; 2002.

Comment: 2. The author may consider to include the supplementary figures 1 and 2 to the main document.

Response: As suggested, I have included the supplementary figures 1 (currently Fig 3) and 2 (currently Fig 4) to the main document. Fig 3 of the earlier version of the manuscript is replaced with the supplementary figure 1 (currently Fig 3). The current Fig 3 displays health expectancy from 1996 to 2016 whereas the previous Fig 3 displayed health expectancy from 2009 to 2016.

Thank you very much for your consideration. 

Reviewer #2:

Comment: The authors attempt to provide essential insights on disability free life expectancy and correctly summarize its necessity vis-à-vis just LE. It is a timely assessment given the ageing population in Bangladesh.

Response: Thank you very much for your positive comments.

Major concerns:

Comment: 1. The authors provide information on various data sources available for disability and life tables- can be shifted to supplementary . They must mention and with details only the data sets used in main manuscript.

Response: As suggested, I have moved the entire ‘Available data’ section to supplementary text (S1 Text). The WVS, SVRS and BSVS are elaborated at their first appearance in ‘Analytical data’ section. I have also stated the following in Methods section (lines# 133-135) so that the readers can locate the ‘Available data’ section from the supplementary files.

“……Available mortality and morbidity data for Bangladesh along with their formats and sources are discussed in detail in supplementary text (S1 Text). Only analytical data are discussed below.”

Comment: 2. Since SRH and disability rates are both used, the authors should provide more information on the pros and cons of these- and justify a comparison across time with two different measures.

Response: I appreciate your observation. I did include the limitation of using self-reported disability in the earlier version of the manuscript, but I missed to add the bias that might have been introduced by using SRH as a measure of morbidity. I have added the following to the limitation section (lines# 345-352):

“…The SRH was also utilized as a measure of morbidity, which may have introduced gender bias in the findings [45]. The single-item SRH was however reported to be able to capture almost the same as objective health status in predicting a short-term mortality among older adults [46]. Due to unavailability of same morbidity measure across the study period, two different subjective morbidity measures ─ SRH and disability ─ were utilized in the current study. They both were found to be consistent with their objective measures, and were reported to predict mortality among older adults in different settings [44,46,47].”

44. Zunzunegui M-V, Alvarado B-E, Béland F, Vissandjee B. Explaining health differences between men and women in later life: A cross-city comparison in Latin America and the Caribbean. Soc Sci Med. 2009;68: 235–242. doi:10.1016/j.socscimed.2008.10.031

45. Case A, Paxson C. Sex differences in morbidity and mortality. Demography. 2005;42: 189–214. doi:10.1353/dem.2005.0011

46. Wuorela M, Lavonius S, Salminen M, Vahlberg T, Viitanen M, Viikari L. Self-rated health and objective health status as predictors of all-cause mortality among older people: a prospective study with a 5-, 10-, and 27-year follow-up. BMC Geriatr. 2020;20: 120. doi:10.1186/s12877-020-01516-9

47. Gobbens RJ, van der Ploeg T. The prediction of mortality by disability among Dutch community-dwelling older people. Clin Interv Aging. 2020;15: 1897–1906. doi:10.2147/CIA.S271800

Comment: 3. The introduction should focus more on literature about SRH and disability instead of various uses of disability free life expectancy

Response: The main focus of this paper is health expectancy. Therefore, life expectancy, health expectancy, and their literature review are articulated in Introduction section. The SRH and disability, mainly because of availability and employability, were utilized as the measures of morbidity, which were combined with mortality information for computing health expectancy. Different morbidity measures could be used if available and employable. The SRH and disability are not the main focus of this study, and the study’s focus and succinctness will be perished if I focus on literature about SRH and disability instead of health expectancy. In addition, I have not found a suitable place in Introduction section, where the literature about SRH and disability can be accommodated.

My response to your comment#2 is partly applicable to respond to this comment. For example, I have added the limitation of using SRH and disability along with their predictability of mortality. The definitions of SRH and disability were in the main document in the earlier version of the manuscript. Now they are shifted to the supplementary text in the light of your suggestion and comment#1.

Minor suggestions:

Comment: 1. Abstract- implications should be discussed in text and mention only major findings here

Response: The following is found ignorable, and has been removed from the first sentence of the Results section of the Abstract. The Results section is revised, and other sections remain same.

“…almost stagnant at 4.6-5.5% during 2009-2012 and at…”

The first sentence is revised as follows:

“With an overall declining trend over the study period and a big drop in disability rates during 2012-2013, the disability rates were observed 1.6-1.7% in 2016.”

Comment: 2. Introduction- line 94: can be just "or USA" instead of repeating entire sentence again

Response: I have eliminated the repetition. I have included the time period for the USA study, and revised the sentence as follows:

“For example, health expectancies were utilized to identify whether there was compression or expansion of morbidity between 1986 and 2004 in Japan [5], and between 1970 and 2010 in the USA [15], whether……”

Thank you very much for your consideration.

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 1

Allen Prabhaker Ugargol

10 Nov 2022

Trends in health expectancy at age 60 in Bangladesh from 1996 to 2016

PONE-D-22-03689R1

Dear Dr. Md. Ismail Tareque,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Allen Prabhaker Ugargol

14 Nov 2022

PONE-D-22-03689R1

Trends in health expectancy at age 60 in Bangladesh from 1996 to 2016

Dear Dr. Tareque:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Allen Prabhaker Ugargol

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Available data.

    (DOCX)

    S1 Table. Poor SRH/ disability prevalence (per 1000) and annual percent change in poor SRH/ disability by gender at age 60 from 1996 to 2016.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    All data are held in public repositories. The sources are mentioned in the Supporting information (S1 Text). Nationally representative data on SRH status by age and gender access can be obtained at www.worldvaluessurvey.org.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES